These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7654449)

  • 21. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The application of antisense technology in ophthalmology].
    Guo Y; Ge J
    Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense therapeutics.
    Holt J
    Mol Med Today; 1996 May; 2(5):184-5. PubMed ID: 8796885
    [No Abstract]   [Full Text] [Related]  

  • 24. Antisense molecules for targeted cancer therapy.
    Wacheck V; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA combination therapy to stop tumor growth.
    Wickstrom E; Smith JB
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense tumor therapy (a dream under construction).
    Kopper L; Kovalszky I
    In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotides for central nervous system tumors.
    Hall WA; Flores EP; Low WC
    Neurosurgery; 1996 Feb; 38(2):376-83. PubMed ID: 8869067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense oligonucleotides as inhibitors of genes that regulate AP-1: pharmacology and clinical development.
    Dean NM; McKay RA; Holmlund J
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):147-51. PubMed ID: 9593055
    [No Abstract]   [Full Text] [Related]  

  • 32. Peptide-conjugated antisense therapy takes a skip ahead.
    Wells DJ
    Mol Ther; 2008 Sep; 16(9):1523-4. PubMed ID: 18725878
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel combined therapy for prostate cancer proves significantly more effective.
    Oncology (Williston Park); 2006 Jun; 20(7):785. PubMed ID: 16841800
    [No Abstract]   [Full Text] [Related]  

  • 34. Exploiting the p53 Pathway for Therapy.
    Cheok CF; Lane DP
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28193768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tumor cell apoptosis and chemosensitization by antisense strategies.
    Rieber M; Strasberg-Rieber M
    Methods Mol Med; 2005; 106():205-14. PubMed ID: 15375318
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic antisense and ribozymes.
    Rossi JJ
    Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marking milestones.
    Steele F
    Nucleic Acid Ther; 2013 Aug; 23(4):243. PubMed ID: 23902359
    [No Abstract]   [Full Text] [Related]  

  • 38. Antisense gene therapy trials underway in patients with CML.
    Oncology (Williston Park); 1996 Sep; 10(9):1411. PubMed ID: 8882929
    [No Abstract]   [Full Text] [Related]  

  • 39. Oligonucleotides in the treatment of leukemia.
    Bayever E; Iversen P
    Hematol Oncol; 1994; 12(1):9-14. PubMed ID: 8194842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
    Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.